GAGNON SECURITIES LLC recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
P.O. BOX 1370 AVENUE OF THE AMERICAS NEW YORK, NY 10019
As of the latest 13F report, the guru’s equity portfolio contained 101 stocks valued at a total of $477.00Mil. The top holdings were PCRX(7.26%), AL(6.68%), and ENSG(5.49%).
According to GuruFocus data, these were GAGNON SECURITIES LLC’s top five trades of the quarter.
Enviva Inc
The guru established a new position worth 297,287 shares in NYSE:EVA, giving the stock a 3.84% weight in the equity portfolio. Shares traded for an average price of $72.98 during the quarter.
On 08/01/2022, Enviva Inc traded for a price of $68.34 per share and a market cap of $4.56Bil. The stock has returned 32.89% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 5 out of 10.
In terms of valuation, Enviva Inc has a price-book ratio of 8.29, a EV-to-Ebitda ratio of -99.04 and a price-sales ratio of 3.35.
The price-to-GF Value ratio is 1.77, earning the stock a GF Value rank of 1.
Enviva Inc
The guru sold out of their 258,040-share investment in FRA:XV6. Previously, the stock had a 2.73% weight in the equity portfolio. Shares traded for an average price of €48.8 during the quarter.
On 08/01/2022, Enviva Inc traded for a price of €66.28 per share and a market cap of €4.67Bil. The stock has returned 142.34% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, Enviva Inc has a price-book ratio of 8.44, a EV-to-Ebitda ratio of -100.49 and a price-sales ratio of 3.43.
The price-to-GF Value ratio is 1.98, earning the stock a GF Value rank of 1.
Alpha & Omega Semiconductor Ltd
GAGNON SECURITIES LLC reduced their investment in NAS:AOSL by 228,552 shares. The trade had a 2.07% impact on the equity portfolio. During the quarter, the stock traded for an average price of $52.02.
On 08/01/2022, Alpha & Omega Semiconductor Ltd traded for a price of $41.88 per share and a market cap of $1.13Bil. The stock has returned 61.14% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Alpha & Omega Semiconductor Ltd has a price-earnings ratio of 2.57, a price-book ratio of 1.36, a price-earnings-to-growth (PEG) ratio of 0.17, a EV-to-Ebitda ratio of 1.67 and a price-sales ratio of 1.55.
The price-to-GF Value ratio is 1.43, earning the stock a GF Value rank of 1.
SomaLogic Inc
GAGNON SECURITIES LLC reduced their investment in NAS:SLGC by 725,033 shares. The trade had a 1.26% impact on the equity portfolio. During the quarter, the stock traded for an average price of $8.84.
On 08/01/2022, SomaLogic Inc traded for a price of $4.85 per share and a market cap of $884.11Mil. The stock has returned 0.00% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10. There is insufficient data to calculate the stock’s profitability rating.
In terms of valuation, SomaLogic Inc has a price-book ratio of 1.44, a EV-to-Ebitda ratio of -10.64 and a price-sales ratio of 9.38.
Castlight Health Inc
The guru sold out of their 4,087,486-share investment in NYSE:CSLT. Previously, the stock had a 0.94% weight in the equity portfolio. Shares traded for an average price of $2.01 during the quarter.
On 08/01/2022, Castlight Health Inc traded for a price of $2.05 per share and a market cap of $335.49Mil. The stock has returned 12.02% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, Castlight Health Inc has a price-book ratio of 2.61, a EV-to-Ebitda ratio of -124.02 and a price-sales ratio of 2.27.
The price-to-GF Value ratio is 1.41, earning the stock a GF Value rank of 3.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
